The large number of lawsuits against GlaxoSmithKline Plc and Bristol-Myers Squibb Co., which have been sort of hanging around, are now moving toward trials. That important development comes because of the U.S. Supreme Court’s March 4th ruling in the Levine v. Wyeth case. That decision broke a logjam of cases against drug manufacturers in state and federal courts. The result in that case has already affected more than 250 lawsuits involving at least ten companies that were in limbo before the ruling.
Contact us today for a free legal consultation with an experienced attorney.
Fields marked *may be required for submission.
If you would like to subscribe to the Jere Beasley Report digital edition, simply visit our Subscriptions page and provide the necessary information or call us at 800-898-2034.
Attorney Advertising - Prior results do not guarantee a similar outcome.